Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, October 27, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

 MIDDAY BREAKOUTS REPORT - THURSDAY, JULY 1ST, 2010
Previous Mid Day Report Next Mid Day Report >>>

DOW 9717.26 -56.76 (-0.58%) | NASDAQ 2093.42 -15.82 (-0.75%) | S&P 500 1021.94 -8.77 (-0.85%)
Time of Screening : 7/1/2010 12:07:59 PM         Report Released : 7/1/2010 1:12:42 PM
Price is: Above 52W High and Less Than 52W High but within 8% of the 52 Week High
Volume Is: At least 57.5% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page
Symbol/Exchange
Company Name
Industry Group
PRICE CHANGE
(%Change)
Day High Volume
(% DAV)
(50 DAV)
52 Wk Hi
% From Hi
Date
Featured
Price
Featured
Pivot Point
Max Buy
NEM - NYSE
Newmont Mining Corp
$58.87 -2.87
-4.65%
$61.65 6,564,272
67.09% of 50 DAV
50 DAV is 9,784,600
$62.62
-5.99%
6/22/2010 $59.60 PP = $59.67
MB = $62.65
Most Recent Note - 7/1/2010 12:58:29 PM
Y - Pulling back today from its 52-week high and slumping below prior chart highs and its pivot point amid a mostly negative market (M criteria) environment. Volume behind recent gains has been below the minimum guidelines (since its mid-May breakout faltered). The America-based mining firm has very reassuring leadership (L criteria) from other Mining - Gold/Silver/Gems industry firms as a favorable backdrop. No overhead supply remains to act as resistance. Featured in a 6/22/10 Stock Bulletin with annotated graph (read here).
>>> The latest Featured Stock Update with an annotated graph appeared on 6/22/2010. Click here.
View all notes | Alert me of new notes | Company Profile | SEC | News | ChartC A N S L I M

Symbol - Exchange - Industry Group
Company Name
Last Chg Day
High
52 WK Hi % From Hi Volume
% DAV
DAV
ABC - NYSE - Medical-Whlsle Drg/Suppl
Amerisourcebergen Corp
$30.79 -0.96
-3.02%
$31.64 $33.27 -7.45% 4,073,080
92.02%
4,426,300
Most Recent Note for ABC - 7/1/2010 12:10:46 PM
Gapped down today and violated its 50 DMA line amid widespread market weakness (M criteria). It traded up in 14 out of the past 16 months. Noted in recent mid-day reports - "Earnings showed better increases in the 2 latest quarters but prior comparisons have been below guidelines and sales revenues growth has been below guidelines. It shown steady annual earnings (A criteria) growth in recent years."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
AMT - NYSE - TELECOMMUNICATIONS - Diversified Communication Serv
American Tower Reit
$43.65 -0.85
-1.91%
$44.78 $46.21 -5.54% 2,571,540
59.63%
4,312,300
Most Recent Note for AMT - 7/1/2010 12:19:52 PM
Lack of leadership (L criteria) in the Telecom Services - Wireless group and broader market (M criteria) weakness are among the main overriding concerns. In recent weeks it has encountered distributional pressure after rallying near multi-year highs in the $46 area. Quarterly sales revenues increases have steadily been in the +7-11% range, not especially strong or accelerating impressively, yet its annual and quarterly earnings history has been strong.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
AZO - NYSE - RETAIL - Auto Parts Stores
Autozone Inc
$193.12 -0.10
-0.05%
$193.46 $198.22 -2.57% 393,001
64.33%
610,900
Most Recent Note for AZO - 7/1/2010 12:22:34 PM
Overcame early weakness today after pulling back near its 50 DMA line amid widespread market (M criteria) weakness. It has held up well since its considerable gain with heavy volume on 5/25/10 for a new 52-week high. Earnings increases have been borderline with the minimum guidelines in the past 3 quarters while sales revenues have increased by only +1-10% in the past 4 quarterly comparisons. While consumers are fixing their old cars and holding off on new car purchases, AZO and similar players in the auto-repair arena have shown great relative strength. Guidelines of the investment system, however, call for current earnings per share +25% or more, and acceleration in recent quarters is important. Also, quarterly sales should also be up at least +18%, +25% or more and ideally accelerating over prior quarters.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
EW - NYSE - HEALTH SERVICES - Medical Appliances & Equipment
Edwards Lifesciences Cp
$54.89 -1.14
-2.03%
$56.18 $56.44 -2.76% 762,555
76.17%
1,001,100
Most Recent Note for EW - 7/1/2010 12:23:50 PM
Pulling back today after a considerable gain for a new 52-week high on the prior session. Noted in prior mid-day reports that it - "endured numerous distribution days since March yet it held up well, and on 5/28/10 its share price was impacted by a 2:1 split . The Medical - Products firm has a slow but steady annual earnings history. Quarterly sales revenues and earnings increases have been below guidelines. With respect to the N criteria, explosive sales revenues increases would be a true indication of great or growing demand for any company's products."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
HAS - NASDAQ - CONSUMER DURABLES - Toys & Games
Hasbro Inc
$40.99 -0.11
-0.27%
$41.71 $43.71 -6.22% 1,530,241
57.52%
2,660,500
Most Recent Note for HAS - 7/1/2010 12:25:53 PM
Consolidating above its 50 DMA line quietly today only -6.6% off its 52-week high. Noted in prior mid-day reports -"Quarterly sales revenues and earnings comparisons have been below guidelines for this toymaker."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
HSP - NYSE - DRUGS - Drug Delivery
Hospira Inc
$56.81 -0.65
-1.12%
$57.89 $58.13 -2.28% 895,804
65.81%
1,361,300
Most Recent Note for HSP - 7/1/2010 12:39:04 PM
This high-ranked Medical - Generic Drugs industry firm is challenging its all-time highs this week, and no overhead supply remains to act as resistance. It rebounded with an impressive streak of gains with volume, rising from May - June lows after finding important support at its 200 DMA line. Recent quarters showed sales revenues increases gradually accelerating after a slight downturn. Earnings per share increases have been above the +25% guideline in 3 of the past 4 comparisons versus the year ago period. It has steady earnings history, but not a very strong annual earnings (A criteria) growth record. Leadership in the Medical - Generic Drugs group (L criteria) is very reassuring, while the weak market environment (M criteria) is an overriding concern.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
MMP - NYSE - ENERGY - Oil & Gas Pipelines
Magellan Midstream Ptnrs
$46.03 -0.72
-1.54%
$46.81 $48.60 -5.29% 201,645
60.39%
333,900
Most Recent Note for MMP - 7/1/2010 12:48:33 PM
The 2 latest quarterly comparisons show greatly improved sales revenues and earnings versus the year ago period. Concerns are raised by the up and down annual earnings (A criteria) history for this Master Limited Partnership in the Oil and Gas - Transportation/Pipeline industry.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
MNRO - NASDAQ - RETAIL - Auto Parts and Sercices
Monro Muffler Brake
$39.60 +0.07
0.18%
$40.50 $40.64 -2.56% 159,156
63.71%
249,800
Most Recent Note for MNRO - 7/1/2010 12:56:25 PM
Rallying today for a 3rd consecutive gain against a negative market environment (M criteria). It reached a new 52-week high and new all-time high this week, leaving it clear of any resistance due to overhead supply. It and similar players in the auto-repair arena have shown recent strength while consumers are fixing their old cars and holding off on new car purchases. Earnings and sales revenues increases have been much stronger in recent quarterly comparisons. While the C criteria may be sufficiently satisfied, its annual earnings (A criteria) growth rate has been not especially strong. Additionally, in 6 of its 8 most recent quarterly earnings comparisons there are blue triangles beside the earnings figure on the chart service used by our experts - which indicates pre-tax, non-recurring items were included (where possible, such items are normally removed to provide data better suited for comparison).
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
NVO - NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
$80.75 -0.27
-0.33%
$81.54 $85.86 -5.95% 384,487
110.77%
347,100
Most Recent Note for NVO - 7/1/2010 1:00:23 PM
This Denmark-based Medical - Ethical Drug firm is enduring distributional pressure today while consolidating just above its 50 DMA line. It has pulled back since gapping up and being noted in the 6/18 and 6/21 mid-day reports - "It has earned high ranks after demonstrating strong steady annual earnings (A criteria) growth. Quarterly comparisons show sales and earnings increases mostly below guidelines of the fact-based investment system."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
SRCL - NASDAQ - MATERIALS & CONSTRUCTION - Waste Management
Stericycle Inc
$64.88 -0.70
-1.07%
$65.83 $67.03 -3.21% 590,786
69.04%
855,700
Most Recent Note for SRCL - 7/1/2010 1:08:48 PM
This high-ranked Pollution Control firm has steadily produced earnings and sales growth slightly under the +25% guideline. It has traded heavier volume while holding its recent gains stubbornly. Earlier this week, amid a negative market (M criteria) environment, it quietly touched a new all-time high.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
WCN - NYSE - MATERIALS & CONSTRUCTION - Waste Management
Waste Connections Inc
$34.46 -0.43
-1.23%
$34.81 $37.07 -7.04% 261,511
57.93%
451,400
Most Recent Note for WCN - 7/1/2010 1:11:45 PM
Recent quarterly comparisons showed increases near the +25% minimum guideline, but its previous quarterly comparisons and annual earnings track record have been below the fact-based system's guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

 We appreciate any feedback members may wish to send via the inquiry form here.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us